The CooperCOO +4.04%85 Median PS Value is $114.60 as of Jun. 24, 2026, which is 8715% above its 10-year median of 1.30. GuruFocus rates COO with a GF Score™ of 85/100 and a GF Value™ of $100.85 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 337 Medical Devices & Instruments companies, The Cooper ranks better than 63.8% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. The Cooper's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was $21.428. The Cooper's 10-Year median PS Ratio is 5.3481. Therefore, the Median PS Value for today is $114.60.
As of today (2026-06-24), The Cooper's share price is $68.83. The Cooper's Median PS Value is $114.60. Therefore, The Cooper's Price to Median PS Value for today is 0.60.
The historical rank and industry rank for The Cooper's Median PS Value or its related term are showing as below:
COO'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.55 Med: 1.3 Max: 1.82
Current: 0.6
During the past 13 years, the highest Price to Median PS Value of The Cooper was 1.82. The lowest was 0.55. And the median was 1.30.
COO's Price-to-Median-PS-Value is ranked better than 63.8% of 337
companies
in the Medical Devices & Instruments industry
Industry Median: 0.7
vs COO: 0.60
The Cooper (NAS:COO) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
The Cooper's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
68.83
/
114.60
=
0.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper Median PS Value Related Terms
The Cooper Median PS Value Historical Data
* Premium members only.
The historical data trend for The Cooper's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COO vs ALGN, SOLV, BAX: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, The Cooper's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where The Cooper's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.3481.
The Cooper's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $21.428.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (COO) has a Median PS Value of $114.60 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on The Cooper and its competitors. This is 8715% above median its historical median of 1.30. Over the past decade, The Cooper's Median PS Value has ranged from 0.55 to 1.82. According to the industry distribution chart, The Cooper ranks #122 out of 337 companies in the Medical Devices & Instruments industry, placing it in the top 36.2%.
Is The Cooper's Median PS Value too high?
The Cooper's current Median PS Value of $114.60 is 8715% above median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 1.82. The Medical Devices & Instruments industry median Median PS Value is 0.70. The Cooper's value of $114.60 is 16271.4% above this industry median. Based on the distribution chart, The Cooper ranks #122 out of 337 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, The Cooper has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Median PS Value compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #122 out of 337 companies for Median PS Value. This puts The Cooper in the upper half of its industry. The industry median Median PS Value is 0.70. The Cooper's value of $114.60 is 16271.4% above this benchmark. Historically, The Cooper's own Median PS Value has ranged from 0.55 to 1.82 over the past decade. While the company's 10-year median is 1.30 vs. the industry median of 0.70, The Cooper has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.70, based on 337 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cooper's current Median PS Value of $114.60 is 16271.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on The Cooper and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current Median PS Value is $114.60, which is 8715% above median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.85, compared to a current price of $68.83 — trading 31.8% below its estimated fair value. The current Median PS Value is $114.60, which is 8715% above median its 10-year median of 1.30 and 16271.4% above the Medical Devices & Instruments industry median of 0.70. The Cooper's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For The Cooper (COO), the current Median PS Value is $114.60 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of $68.83 is trading 31.8% below its estimated GF Value™ of $100.85.
GuruFocus considers The Cooper to be Significantly Undervalued.
Key valuation signals for COO:
Median PS Value: $114.60 (8715% above median its 10-year median of 1.30)
GF Value™: $100.85 vs. price of $68.83 (31.8% below fair value)
Industry Position: 16271.4% above the Medical Devices & Instruments median (#122 of 337)
No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
85GF Score
Get the complete analysis for COO
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COO has been successfully added to your 
